PROSAH-MPC, a collaborative research project among neurosurgical centers in China, focuses on aneurysmal subarachnoid hemorrhage (aSAH). Its aim is to identify prognostic factors and develop robust prediction models for complications, disability, and mortality in aSAH patients. By leveraging a large, multi-center, prospective cohort design, PROSAH-MPC aims to overcome limitations of past studies and provide a more comprehensive understanding of the disease.
Subarachnoid hemorrhage confirmed by computed tomography (CT);
Cerebral angiography (CTA) and digital subtraction angiography (DSA) examination confirming intracranial aneurysm rupture as the cause of the subarachnoid hemorrhage;
Blood routine, biochemical function, blood coagulation function, and craniocerebral CT performed within 24 hours of symptom onset;
Underwent aneurysm clipping by surgery or endovascular embolization within 72 hours after-onset.
Aneurysm rupture bleeding time exceeding 24 hours before hospital admission;
Incomplete image data or blood test information;
Long-term use of anticoagulant medications such as aspirin or warfarin;
Admitted to hospital with active infectious diseases;
Second Affiliated Hospital of Nanchang University
Lead sponsor
Panzhihua Central Hospital
Collaborator
Zhujiang Hospital
Collaborator
Southwest Hospital, China
Collaborator
Renmin Hospital of Wuhan University
Collaborator